RSS   Newsletter   Contact   Advertise with us
Post Online Media

Oramed appoints Roy Eldor as chief medical director

OramedOramed Pharmaceuticals Inc., a developer of oral drug delivery systems, appointS Roy Eldor to the newly created position of chief medical director.
Article continues below

READ MORE Oramed Pharmaceuticals appoints Ronald Law as CSO

Dr. Eldor is an endocrinologist, internist and researcher with over twenty years of clinical and scientific experience. He is currently Director of the Diabetes Unit at the Institute of Endocrinology, Metabolism & Hypertension, Tel-Aviv Sourasky Medical Center.

Prior to that, Dr. Eldor served as Principal Scientist at Merck Research Laboratories, Clinical Research – Diabetes & Endocrinology, Rahway, New Jersey.

He has previously served as a senior physician in internal medicine at the Diabetes Unit in Hadassah Hebrew University Hospital, Jerusalem, Israel; the Diabetes Division at the University of Texas Health Science Center in San Antonio, Texas (under the guidance of Dr. R.A. DeFronzo).

Dr. Eldor is a recognized expert, with over 35 peer reviewed papers and book chapters and has been an invited speaker to numerous international forums.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy